SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
103 hedge funds and large institutions have $436M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2013 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 2 closing their positions.
1,550% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 2
115% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 20
43% more funds holding
Funds holding: 72 → 103 (+31)
26% more capital invested
Capital invested by funds: $345M → $436M (+$91.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$87.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.69M |
| 3 |
Millennium Management
New York
|
+$7.16M |
| 4 |
PCP
Perimeter Capital Partners
Atlanta,
Georgia
|
+$5.54M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$5.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$23.8M |
| 2 |
VAM
Visium Asset Management
New York
|
-$11.3M |
| 3 |
Morgan Stanley
New York
|
-$9.34M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$7.95M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$7.7M |
SGNT Hedge Fund Activity: Q3 2013 in Review
103 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q3 2013, worth a combined $436M — up 26% from $345M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new SGNT positions and 2 closed out — a net gain of 31 holders — while 43 added to existing stakes and 20 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $87.9M. The largest seller was Deerfield Management, cutting an estimated $23.8M.
- 103 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q3 2013, up from 72 in Q2 2013.
- Funds reported $436M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q3 2013, up 26% quarter-over-quarter.
- 33 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q3 2013 and 2 closed out, a net change of +31 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2013 was Franklin Resources, an estimated $87.9M added.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q3 2013 was Deerfield Management, an estimated $23.8M sold.
Based on aggregated 13F filings for Q3 2013.